University of Illinois at Chicago, College of Nursing, 845 South Damen Avenue, Chicago, IL, 60612, USA.
Sleep Med. 2022 Jul;95:120-125. doi: 10.1016/j.sleep.2022.04.017. Epub 2022 Apr 22.
OBJECTIVE/BACKGROUND: Insomnia is one of the most commonly reported symptoms among people with chronic obstructive pulmonary disease (COPD). Prior research evaluated the psychometric properties of the Insomnia Severity Index (ISI) with various populations, but no studies have examined the measurement properties of the instrument in the COPD population. This study aimed to determine the reliability and validity of the ISI for the COPD population.
PATIENTS/METHODS: This study included 96 people with COPD and insomnia. As psychometric properties, the ISI's internal consistency, factor structure, and criterion validity were examined with this sample. Exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) were used to evaluate construct validity. Correlations between scores for the ISI and for measures of depression, anxiety, fatigue, and dyspnea were examined to determine criterion validity.
The Cronbach's alpha value for the ISI was 0.79, indicating good internal consistency. In the EFA, a single ISI factor with an eigenvalue of 3.19 accounted for 45.6% of the variance. CFA indicated adequate construct validity, and interference of sleep problems with daytime functioning and level of distress caused by sleep difficulties showed the highest factor loadings (both 0.78). Criterion validity was supported by significant, weak to moderate correlations between scores for the ISI and for measures of depression, anxiety, fatigue, and dyspnea.
The results provide evidence that the ISI has good reliability and validity for measuring insomnia severity in the COPD population.
目的/背景:失眠是慢性阻塞性肺疾病(COPD)患者最常见的症状之一。先前的研究评估了失眠严重程度指数(ISI)在不同人群中的心理测量特性,但没有研究在 COPD 人群中检验该工具的测量特性。本研究旨在确定 ISI 在 COPD 人群中的可靠性和有效性。
患者/方法:本研究纳入了 96 名患有 COPD 和失眠的患者。作为心理测量特性,使用该样本检验了 ISI 的内部一致性、因子结构和效标效度。采用探索性因子分析(EFA)和验证性因子分析(CFA)来评估结构效度。通过检验 ISI 评分与抑郁、焦虑、疲劳和呼吸困难测量值之间的相关性来确定效标效度。
ISI 的克朗巴赫 α 值为 0.79,表明内部一致性良好。在 EFA 中,一个具有 3.19 特征值的单一 ISI 因子解释了 45.6%的方差。CFA 表明具有较好的结构效度,并且睡眠问题对白天功能的干扰以及由睡眠困难引起的苦恼程度的得分显示出最高的因子负荷(均为 0.78)。ISI 评分与抑郁、焦虑、疲劳和呼吸困难测量值之间存在显著的、弱到中度的相关性,支持了效标效度。
结果表明,ISI 在 COPD 人群中测量失眠严重程度具有良好的可靠性和有效性。